T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF.A
2626
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $114K | ﹤0.01% |
13,415
+1,647
| +14% | +$13.1K |
|
2627
ClearPoint Neuro
CLPT
$463M
| $113K | ﹤0.01% |
22,366
| – | – |
|
|
HTBK
2628
DELISTED
Heritage Commerce
HTBK
| $113K | ﹤0.01% |
13,268
+1,348
| +11% | +$12K |
|
|
VOXX
2629
DELISTED
VOXX International Corporation Class A
VOXX
| $113K | ﹤0.01% |
14,127
| – | – |
|
2630
Standard BioTools
LAB
$311M
| $112K | ﹤0.01% |
38,400
| – | – |
|
2631
OmniAb
OABI
$526M
| $112K | ﹤0.01% |
21,497
+2,593
| +14% | +$13.8K |
|
2632
Costamare
CMRE
$1.74B
| $111K | ﹤0.01% |
11,458
+547
| +5% | +$5.57K |
|
|
MRSN
2633
DELISTED
Mersana Therapeutics
MRSN
| $111K | ﹤0.01% |
3,485
-1,289
| -27% | -$61.3K |
|
2634
Noodles & Co
NDLS
$99.6M
| $111K | ﹤0.01% |
5,601
+139
| +3% | +$3.35K |
|
|
CHMI
2635
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $110K | ﹤0.01% |
29,562
+10,500
| +55% | +$43K |
|
2636
iShares S&P 500 Growth ETF
IVW
$77.9B
| $110K | ﹤0.01% |
+1,597
| New | +$113K |
|
2637
Lexicon Pharmaceuticals
LXRX
$1.05B
| $110K | ﹤0.01% |
100,691
-7,695
| -7% | -$13.5K |
|
|
IVAC
2638
DELISTED
Intevac Inc
IVAC
| $110K | ﹤0.01% |
35,215
| – | – |
|
|
EU
2639
enCore Energy
EU
$235M
| $109K | ﹤0.01% |
33,404
+4,677
| +16% | +$12.1K |
|
|
FPI
2640
Farmland Partners
FPI
$427M
| $109K | ﹤0.01% |
10,586
+556
| +6% | +$6.34K |
|
2641
uniQure
QURE
$3.14B
| $109K | ﹤0.01% |
16,100
-190,615
| -92% | -$1.72M |
|
2642
Rigel Pharmaceuticals
RIGL
$766M
| $109K | ﹤0.01% |
10,025
+138
| +1% | +$1.66K |
|
2643
SmartRent
SMRT
$287M
| $109K | ﹤0.01% |
41,725
+4,376
| +12% | +$14.9K |
|
2644
Pangaea Logistics
PANL
$496M
| $108K | ﹤0.01% |
18,229
+733
| +4% | +$4.57K |
|
|
LICY
2645
DELISTED
Li-Cycle Holdings Corp.
LICY
| $108K | ﹤0.01% |
3,795
+369
| +11% | +$14.8K |
|
2646
Quantum Corp
QMCO
$899M
| $107K | ﹤0.01% |
8,760
+1,440
| +20% | +$23.8K |
|
2647
QuinStreet
QNST
$1.21B
| $107K | ﹤0.01% |
11,909
+1,717
| +17% | +$15.9K |
|
2648
Mission Produce
AVO
$1.14B
| $106K | ﹤0.01% |
+10,879
| New | +$115K |
|
2649
TaskUs
TASK
$658M
| $106K | ﹤0.01% |
10,200
| – | – |
|
2650
Mammoth Energy Services
TUSK
$161M
| $106K | ﹤0.01% |
22,752
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.